Dr. Goldkorn on the Methods Used to Predict Chemotherapy Benefit in Bladder Cancer - OncLive

Dr. Goldkorn on the Methods Used to Predict Chemotherapy Benefit in Bladder Cancer - OncLive
Amir Goldkorn, MD, discusses the methods utilized to predict chemotherapy benefit in bladder cancer.
Amir Goldkorn, MD, associate director, Translational Sciences, University of Southern California (USC) Norris Comprehensive Cancer Center, associate professor of Medicine, the Keck School of Medicine… [+1012 chars] Read More



Related Stories

See All